Aeroplysinin-1, Lymphom a Cells, Epitheliom a Cells (± )-A ero p lysin in -l, an optically active 1.2-dihydroarene-1.2-diol. was isolated from the marine sponges Verongia aerophoba (+-isom er) and lanthella ardis ( -isomer). For the experim ents presented we used the -f-isom er from Verongia aerophoba. Here we describe the hitherto un known biological and pharmacological property of this com pound to display pronounced anti cancer activity against L5178y mouse lymphoma cells (E D sn: 0.5 (am). Friend erythroleukem ia cells (E D 50: 0.7 jam), hum an mamma carcinoma cells (E D 5": 0.3 [am) and hum an colon carcinom a cells (E D S(): 3.0 ^m) in vitro. Furtherm ore, aeroplysinin caused a preferential inhibition of pH ]thym idine (dThd) incorporation rates in L5178y mouse lymphoma cells if com pared with murine spleen lymphocytes in vitro. At concentrations betw een 1.1 and 28.5 |.im, the [3H ]dThd incorporation rates in L5178y cells were suppressed to 2 8 % -0% but only to 78% -18% in murine spleen lymphocytes. The same differential effect in vitro was found with the following epithelial cells: 14.70 |im of the compound were required to inhibit normal hum an fibroblasts to 50% , but only 2.9 [am in the assays with human malign keratinocytes or malignant m elanom a cells to observe the same inhibitory effect. M oreover, aeroplysinin-1 displayed antileukem ic activity in vivo using the L5178y cell/NM RI mouse system; adm inistered at a dose of 50 mg/kg for five consecutive days, the T/C (% ) value was determ ined to be 338. Prelim inary toxicology studies revealed an acute LD,,, of 202 mg/kg and a subacute LD 50 of 150 mg/kg. Aeroplysinin-1 is neither a direct m utagen nor a prem utagen in the umulSalmonella typhimurium test system.
Introduction
Aeroplysinin-1, an l,2-dihydroarene-l,2-diol with the chemical structure of [l-(3 ',5 '-d ib ro m o -l',2 '-dihydroxy-4'-methoxycyclohexa, 3'.5'-dien-l'-yl)-methylcyanide] (Fig. 1 ) is a naturally occurring tyro sine m etabolite from the marine sponge Verongia aerophoba [1 -3] . This com pound has been de scribed to display at a concentration of 2 0 -1 0 0 ng/ml some antibacterial activity in vitro [1, 3] ; adminis tered in vivo at a dose of 128 mg/kg the compound did not protect mice against bacterial infections [3] . Now we describe that aeroplysinin-1 displays a pronounced cytostatic activity against a series of transform ed cells, but not against the related normal cells in vitro. M oreover, we show that aeroplysinin-1 has an antileukemic activity in the L5178y cell/ NM RI mouse system in vivo. 
Materials and Methods

Concanavalin
Aeroplysinin-1
The compound (mol. wt. 339.6; ref. [3] ) was iso lated from the sponge Verongia aerophoba collected in the Bay of K otor (Yugoslavia) as follows. The fresh sponge (1 kg) was homogenized in a Waring Blender in the presence of acetone, evaporated at 50 °C under reduced pressure. The aqueous material obtained was extracted three times with diethylether. The organic extracts were collected and evaporated. The oil-like residue obtained was chrom atographed on a column of silica gel [1] . A fter recrystallization for two times from chloroform -diethylether ( 1 :1 ) 1.5 g of aeroplysinin-1 was obtained from 100 g of dried material. The m aterial was spectroscopically (ultra-violet, infra-red) and chromatographically (thin layer chrom atography) pure. The identity with the described compound [1] [2] [3] was established on the basis of spectroscopic examinations ('H NMR; 13C NM R; MS [E/I Cs Fab], UV and IR).
For the in vitro tests, the compound was dissolved in 0 .1 % dimethyl sulfoxide (final concentration); at this concentration dimethyl sulfoxide had no influ ence on cell growth. For the application in vivo aeroplysinin-1 was suspended in methylcellulose [4] ,
Cell culture
L5178y mouse lymphoma cells [5] were grown in E agle's minimum essential medium supplemented with 10% horse serum in roller tube cultures [6 ] , For the dose-response experim ents, 5-ml cultures were initiated by inoculation of 5 x 1 0 3 cells/ml and were incubated at 37 °C for 48 or 72 h; the controls showed a population doubling time of 10.5 h. The cell growth was determ ined by cell count with a Cytocomp counter (128-channel counter, system Michaelis; M ainz, West Germany) with a 32-channel size-distribution plotter; calibration of the counter was perform ed with paper mulberry pollen (diame ter: 13.5 |j,m; Hollister-Stier, Lab.; Coulter). The volume distribution of L5178y cells for treated and untreated cultures was determ ined as described [7] , For the determ ination of the effect of aeroplysinin-1 on the [3H]dThd incorporation into DN A , 5-ml sus pensions of exponentially growing cells at 1 0 0 , 0 0 0 cells/ml were treated for 24 h with the compound.
['H]dThd (2 (iCi/ml; 134 nM) was added 2 h prior to harvest of the cultures. Samples of 1 ml were ana lyzed for acid-insoluble radioactivity [8 ] . The incor poration rate of the controls was 6.69 x 103 dpm/ 1 0 6 cells x 2 h.
Friend erythroleukem ia cells derived from a clone of Friend virus-transformed 745 A cells [9] were grown in Joklik minimal essential medium sup plem ented with 10% fetal calf serum. For dose-response experim ents, 5-ml cultures (3 x 103 cells/ml) were incubated at 37 °C for 48 or 72 h; the controls showed a population doubling time of 1 1 . 8 h.
Human malign melanoma cells (derived from a 31 years old male European; ATCC CRL 1424) [10] were grown in plastic flasks in RPMI-1640 medium supplem ented with 1 0 % calf serum and cultured in a fully humidified atm osphere of 5% CO : and air at 37 °C. The population doubling time was 24 h. For the determ ination of the cytostatic activity, caused by aeroplysinin-1 , the cells were seeded at a density of 8 x 105 cells/cm2 and were incubated for 24 h. Then the compound was added and the incubation was continued for additional 48 or 72 h. During the last 2 h 0.1 ^iCi of [3H]dThd/ml (= 6.7 nM) was added. Then the acid precipitable radioactivity was deter mined [8 ] . Incorporation rate of the controls:
Spontaneously transform ed human keratinocytes, kindly provided by Prof. N. E. Fusenig (Heidelberg) [1 1 ], were grown in plastic flasks in Dulbeccos mini mal essential medium in the presence of 1 0 % fetal calf serum in a 10% CCWair atm osphere. The popu lation doubling time was determ ined to be 48 h. The influence of aeroplysinin-1 on the incorporation rate of [3H]dThd was determ ined as described above (control: 1 . 2 x 1 0 3 dpm /1 0 6 cells/ 2 h).
Normal human fibroblasts were obtained from the skin of an upper arm as follows. Small pieces (0.5 cm2) were placed onto chicken plasma coated microtiter plates (Difco) and incubated in plastic flasks in RPMI-1640 medium with 20% fetal calf serum at 37 °C in 5% C 0 2/air. A fter 1 week the out grown fibroblasts were collected and dissociated with trypsin/ethylenediam inetetraacetic acid [12] , Cells from passages 5-10 were used for the experiments. The population doubling time was 4.3 days. The in corporation studies, using [3H ]dThd, were per form ed as described above (control: 0.2 x lO 3 dpm/ 1 0 6 cells/2 h).
Mouse spleen cells were prepared and cultured essentially as described [13] . They were suspended at a density of 4 x 106 cells/ml in Dulbeccos minimal essential medium , supplem ented with 1 0 % fetal calf serum. W here indicated the cultures were incubated either in the absence or presence of mitogen ( 2 Hum an colon carcinoma cell line W iDr [14] was grown in plastic flasks in Eagles basal medium, sup plem ented with 10% fetal calf serum at 37 °C in 5% C 0 2/air. The cells were seeded at a density of 200, 100 or 50 cells per 5 ml and incubated in the absence or presence of the com pound for 8 or 12 d. Then the num ber of colonies per 5-ml assays was determ ined. The plating efficiencies [15] were as follows: 62 ± 7% at 200 cells/5 ml, 70 ± 8 % at 100 cells/5 ml and 69 ± 8 % at 50 cells/5 ml. For the inhibition studies, the cultures were initiated with 1 0 0 cells/ 5 ml.
Hum an mamma carcinoma cells (MCF-7 human breast epithelial-like cancer cells) [16] were grown in Eagles basal medium , supplem ented with 10% fetal calf serum at 37 °C in 5% C 0 2 and air. For the doseresponse experim ents the cells were seeded at a den sity of 5 x 103 cells/ml; after 24 h for adaptation the cells were incubated for 48 or 72 h with the com pound. Then the cells were dissociated with trypsin/ ethylenediam inetetraacetic acid [1 2 ] and counted with a hem ocytom eter. The controls showed a popu lation doubling time of 23 h.
Determination o f the 50% inhibitory concentrations in vitro
For the determ ination of the 50% inhibitory con centration of aeroplysinin-1 the following growth param eters were used: (i) For the dose-response ex perim ents the num ber of cells (for L5178y mouse lymphoma cells, Friend erythroleukem ia cells and human mamma carcinoma cells) was determ ined at 7 different concentrations, causing a 10% to 90% in hibition of cell growth; (ii) 5-7 different concentra tions were selected which caused 10% to 90% inhibi tion of [3H]dThd incorporation rate (for L5178y cells, normal human fibroblasts, human peripheral lymphocytes, human malign melanom a cells, human keratinocytes) or (iii) 4 -6 different concentrations, causing a 10% to 90% inhibition of plating efficien cies (human colon carcinoma cells). The control val ues (growth in the absence of com pound) were set at 100%. The ED 50 concentrations were estim ated by logit regression [17] . The data from 5 parallel experi ments each were evaluated; the means (± SD) are given. The slopes of the dose-response curves at the E D 50 values were calculated [17] .
Tumor passage in vivo
The L5178y mouse leukemic cells [5] were main tained by serial transplantations as an ascites tum or in 31 to 35 g male outbred NMRI mice. The appro priate concentration of leukemic cells for i.p. inocu lation ( 1 . 8 x 1 0 8 cells/mouse) was obtained from ascites fluid by dilution in 0.9% NaCl solution. U nder these conditions, 95 -100% of the mice devel oped a palpable ascites and 50% of the animals died between days 13 and 17 post inoculum. The increase in body weight after this period of time was 45 ± 14%; the num ber of leukemic cells increased to 1.3-1.9 x 109/animal.
Chemotherapy
For the evaluation of the anti-tum or effect of aeroplysinin-1 on L5178y leukemia, mice were made leukemic by i. p. injection of 1.8 x 108 cells. One day later the animals were divided into groups of 1 0 mice. One group was used as a control (treated with the methylcellulose solution only), whereas the other groups were treated from day two on, once a day i. p. with the drug for 5 consecutive days.
The antitum or activity was assessed according to the following criteria: the weight changes reflect the differences between the mean weights on the fifth and first days of treatm ent. The percentage increase in median life span over the control (ILS (% ) was calculated [18] and ranked [19] as described). The life span (in percent) was estimated according to the form ula, (T :C ) x 100, [18] [17] . Tum or growth delay (T-C value) was estimated according to the published procedure [18] ; as the predeterm ined num ber of tum or cells in the mice, we chose twice the num ber of L5178y cells initially used for inoculation (3.6 x 108). This num ber was reached in tum or-bearing control mice after 8.9 days; for details see ref. [4] , The log1() cell kill values (per dose) as well as the gross and net cell kill values were calculated from the formula published [18] ; the procedure was outlined previously [4] . The log10 kill values were converted to an arbitrary activity rating as described [18] . The increase of mean weights of treated and untreated controls as well as leukemia bearing mice was determ ined during an 18-days ob servation time. In case of mice with L5178y cells, day 1 is set the day of inoculation.
Toxicity
The toxicity studies were perform ed as follows. Mice (groups of 10 animals per cytostatic dose) were treated either once (acute toxicity), for 5 days (sub acute toxicity), or for 30 consecutive days (subacute toxicity). Signs of a possible toxicity, e.g. loss of weight and hair or nail destruction were checked throughout the period of treatm ent with the com pound. 40 days after the last injection an autopsy was conducted to determine possible morphological alterations.
Mutagenicity testing
The potential mutagenic activity of aeroplysinin-1 was m easured with the uraw-test [20] using Salmonel la typhimurium TA1535 strain, carrying the fused gene um uC '-'lacZ. The levels of umu operon expres sion were determ ined by measuring the ß-galactosidase activity in the cells produced by the fusion gene. ß-Galactosidase was m easured by the proce dure described by Miller [21] . W here indicated S-9 fraction was added to the bacterial culture. This frac tion was isolated from the immature carp liver 48 h after i.p. treatm ent with 3'-m ethylcholanthrene (50 mg/kg), as described [22, 23] , Table I (Table II) . The results show that higher concentrations of the compound are required to influence the incorpora tion rates in lymphocytes than in L5178y cells; e.g. at a concentration of 2.9 the incorporation rates in lymphocytes are reduced only by 40-50% while those in L5178y cells are diminished by almost 100%. In order to rule out the possibility that the compound displayed its cytostatic activity only after a longer period of incubation, two periods were cho sen (48 h and 72 h for all cell types, with the excep tion of human colon carcinoma cells for which the incubation time was 8 or 12 d). In all experiments a 1.4-3.2-times higher concentration was required to inhibit cell growth by 50% after a 48 h-incubation period, compared to the concentration necessary to reach the 50% inhibition after a 72 h-incubation.
Results
Cytostatic activity in vitro
The slopes of the dose-response curves for the ex perim ents with all cell types chosen are steep (Table  I) , resulting in the fact that at a 2 -3-fold E D 50 con centration of the compound for the respective cell type an at least 80% inhibition of growth was meas ured.
Aeroplysinin-1 did not change the mean size of the L5178y cells significantly; the mean value (32 channel-analysis) of the controls was 14.37 ± 5.72 corre sponding to 1172 ± 467 jim3, of cells treated with 1 x E D 50 concentration, 1134 ± 559 ^im3 and of cells, treated with 2 x E D 50, 1221 ± 486 |j.m3. The reversi bility of the effect of the compound on cell growth was determ ined as follows. The cells were incubated in the standard assay for 24 h in the presence of dif ferent concentrations of aeroplysinin-1 ; then the com pound was washed out and the assays were brought to a cell concentration of 5 x 104 cells/ml and incubation was continued for additional 24 h. It was found that up to 3 times the E D 50 concentration, the growth inhibitory effect was completely reversible. A t concentrations of 4 x E D 50 and 5 x E D 50 the cell density at the end of the incubation period was 15.7% and 43.1% , respectively lower than that of the controls.
Cytostatic activity in vivo
The median life span of L5178y lymphoma-bearing control mice was 14.8 d. Aeroplysinin-1 was determ ined to increase the life span of tum or bearing mice considerably (Table III) . The animals were given i. p. injections of the compound for 5 consecu tive days, starting at day 1. At the highest dosage chosen (50 mg/kg/day) the increase of the life span was 3.4-fold compared to the untreated controls. The lower dosage of 30 mg/kg/day likewise increased the life span 2 .0 -fold.
The com pound significantly affected the growth of L5178y cells in vivo (Fig. 2) . While in untreated leukemic mice the num ber of L5178y cells increased from 1. kemic mice (Table IV) . A t a daily dose of 30 mg/kg, the increase of body weight of leukemic mice is as high as the one of non-leukemic mice.
For the evaluation of the activity rating two dosages (10 or 30 mg aeroplysinin-l/kg/day) were chosen (Table V) . Based on the determ inations of the param eters tumor growth delay (T-C value), the ILS and the log10 kill values, the activity rating was found to be as high as -M-> + + + ( 1 0 mg/kg/day) and + + + (30 mg/kg/day), respectively.
Toxicity in vivo
Com pared to the antitum or effect of aeroplysinin-1 in vivo, the toxic effect of this com pound in mice is considerably weaker (Table VI) . E.g., the most effective antitumor activity was observed at 50 mg/kg/d, a dosage which is 2.7 times lower than the 10% subacute lethal dose (L D |0). M oreover, it was determ ined that a daily dose of 30 mg/kg for 30 consecutive days, neither caused any toxicity nor a change of body weight compared to the controls in a group of 1 0 mice. Table IV . Influence of aeroplysinin-1 on mean weight of L5178y cell bearing as well as of control mice. Aeroplysi nin-1 was given daily at the doses indicated for 5 days, starting one day after inoculation of the tum or. The mean weights of the groups (5 animals each) were determ ined after a total observation time of 18 days. The mean weight of the control mice at day 1 was 33 ± 2 g.
Dose of
Increase 40 days after the last injection the animals were sacrificed for autopsy reasons. In no case were any morphological abnormalities detected in the peritoneal cavity.
Mutagenicity
The potential mutagenic activity of aeroplysinin-1 was determ ined in the um u-test, described under M aterials and M ethods. The data summarized in Table VII show that the indirect mutagen benzofa]-pyrene caused an expression of ß-galactosidase (in the presence of S9) of 362 or 732 units at a concentra tion of 0.3 ng/ml and 3.0 (xg/ml, respectively. The di rect m utagen 4-nitroquinoline-l-oxide caused (both in the absence or presence of S9 fraction) an enzyme induction of 882 or 1539 units at 0.3 [xg/ml and 1.0 |ig/ ml, respectively. Using this system both aeroplysi nin-1 (at concentrations between 0 . 0 1 jig/ml and 1 0 (J.g/ml) and its solvent dimethyl sulfoxide ( 1 0 0 0 \igl ml) did not cause any measurable enzyme induction, irrespectively of the presence of the S 9 fraction. In the absence of any compound the enzyme level varied between 180 and 250 units.
Discussion
Since the discovery that sponges live in a speciesspecific symbiosis with microorganisms [24] a jus tified search for antibiotic and cytostatic agents from sponges becam e possible. Two sponge secondary metabolites, 1-ß-D-arabinofuranosylthymine [25, 26] and Avarol [4, 27] are already used in clinics or are under clinical investigation. It is impossible to pre diet the probable pharmacological activity of a puta tive drug in a given sponge; therefore the selection of the test systems applied in a screening program is essential for a future success in the preclinical work.
In the present work we dem onstrate that the sec ondary m etabolite from the marine sponge Verongia aerophoba, aeroplysinin-1 [1, 3] , is a potent cyto static agent in vitro against L5178y mouse lymphoma cells and mouse erythroleukem ia cells and, even more interestingly against human m am ma carcinoma and human colon carcinoma cells. The E D 50 values of aeroplysinin-1 determ ined for these cell lines (0.47-2.96 piM) are significantly lower (P ^ 0.001) than those obtained in cultures with non-transform ed lymphocytes (4-5 ^im). The mode of action of aeroplysinin-1 is apparently not on the level of DN A syn thesis, as can be deduced from the lack of unbal anced growth [28] of treated cells. In comparison to other cytostatic agents, the inhibitory activity of aeroplysinin-1 in the L5178y cell system is high (E D 50: 0.47 (j,m, 72 h incubation): 9-ß-D-arabinofuranosyladenine, E D 50 = 2.9 fiM [29] ; 1-ß-D-arabinofuranosylthym ine, E D 50 = 9.8 ^im [30] ; bleo mycin, E D 50 = 0.9 [31] and distamycin, E D 50 = 13.1 |xm [32] , Aeroplysinin-1 is also shown to be a potent anti tum or agent in vivo, using the L5178y cell/NMRI mouse system. The excellent T/C (% ) value of 338, obtained after treating the mice with a total dosage of 250 mg/kg, is the combined result of the antitum or effect and the low toxicity. Following the arbitrary activity rating proposed [18] , aeroplysinin-1 must be classified to the markedly active (-M----> + + + ) to highly active anticancer agents ( + + + ).
Using the um u-test system, which has been dem onstrated to detect many types of DNA-damaging agents, such as base change mutagens, frameshift mutagens or oxidative mutagens [2 0 ], aeroplysinin-1 turned out to be neither a direct nor an indirect mutagen.
The present study strongly indicates the potential usefulness of aeroplysinin-1 as a cytostatic agent.
